Lesage, Michel

Lesage, Michel

Address: 1001 boulevard Mont-Royal, Appt. 502, Montreal, Quebec H2V 2H4

Country: Canada

Phone: 1 514 277 7714

Fax: 1 514 277 5221

Past position(s): Medical Officer, International Labour Office, Geneva

Education: MD, 1962, Laval University, Quebec; MD, 1962, Laval University, Quebec; CSPQ, 1981, College of Medicine, Quebec

Despite all the national and international energies devoted to their prevention, pneumoconioses are still very present both in industrialized and developing countries, and are responsible for the disability and impairment of many workers. This is why the International Labour Office (ILO), the World Health Organization (WHO) and many national institutes for occupational health and safety continue their fight against these diseases and to propose sustainable programmes for preventing them. For instance, the ILO, the WHO and the US National Institute for Occupational Safety and Health (NIOSH) have proposed in their programmes to work in cooperation on a global fight against silicosis. Part of this programme is based on medical surveillance which includes the reading of thoracic radiographs to help diagnose this pneumoconiosis. This is one example which explains why the ILO, in cooperation with many experts, has developed and updated on a continuous basis a classification of radiographs of pneumoconioses that provides a means for recording systematically the radiographic abnormalities in the chest provoked by the inhalation of dust. The scheme is designed for classifying the appearances of posterio-anterior chest radiographs.

The object of the classification is to codify the radiographic abnormalities of pneumoconioses in a simple, reproducible manner. The classification does not define pathological entities, nor take into account working capacity. The classification does not imply legal definitions of pneumoconioses for compensation purposes, nor imply a level at which compensation is payable. Nevertheless, the classification has been found to have wider uses than anticipated. It is now extensively used internationally for epidemiological research, for the surveillance of those industry occupations and for clinical purposes. Use of the scheme may lead to better international comparability of pneumoconioses statistics. It is also used for describing and recording, in a systematic way, part of the information needed for assessing compensation.

The most important condition for using this system of classification with full value from a scientific and ethical point of view is to read, at all times, films to be classified by systematically referring to the 22 standard films provided in the ILO International Classification set of standard films. If the reader attempts to classify a film without referring to any of the standard films, then no mention of reading according to the ILO International Classification of Radiographs should be made. The possibility of deviating from the classification by over or under reading is so risky that his or her reading should not be used at least for epidemiological research or international comparability of pneumoconioses statistics.

The first classification was proposed for silicosis at the First International Conference of Experts on Pneumoconioses, held in Johannesburg in 1930. It combined both radiographic appearances and impairment of lung functions. In 1958, a new classification based purely on radiographic changes was established (Geneva classification 1958). Since, it has been revised several times, the last time in 1980, always with the objective of providing improved versions to be extensively used for clinical and epidemiological purposes. Each new version of the classification promoted by the ILO has brought modifications and changes based on international experience gained in the use of earlier classifications.

In order to provide clear instructions for the use of the classification, the ILO issued in 1970 a publication entitled International Classification of Radiographs of Pneumoconioses/1968 in the Occupational Safety and Health Series (No. 22). This publication was revised in 1972 as ILO U/C International Classification of Radiographs of Pneumoconioses/1971 and again in 1980 as Guidelines for the use of ILO International Classification of Radiographs of Pneumoconioses, revised edition 1980. The description of standard radiographs is given in table 1.

Table 1. Description of standard radiographs

1980 Standard
radiographs showing Small opacities   Pleural thickening  
      Chest wall      
  Technical quality Profusion Shape-
size Extent Large opacities Circum-
scribed (plaques) Diffuse Diaphragm Costo-
phrenic 
angle 
obliteration Pleural calcification Symbols Comments
0/0 
(example 1) 1 0/0 No No No No No No None Vascular pattern is well illustrated
0/0 
(example 2) 1 0/0 No No No No No No None Also shows vascular pattern, but not as clearly as example 1
1/1; p/p 1 1/1 p/p R    L
x    x
x    x
x    x A No No No No No rp. Rheumatoid pneumoconiosis in left lower zone. Small opacities are present in all zones, but the profusion in the right-upper zone is typical of (some would say a little more profuse than) that classifiable as category 1/1
2/2; p/p 2 2/2 p/p R    L
x    x
x    x
x    x No No No No No No pi; tb. Quality defect: radiograph is too light
3/3; p/p 1 3/3 p/p R    L
x    x
x    x
x    x No No No No Yes
R    L
x    – No ax. None
1/1; q/q 1 1/1 q/q R    L
x    x
x    x
–    – No No No No No No None Illustrates profusion 1/1 better than shape or size
2/2; q/q 1 2/2 q/q R    L
x    x
x    x
x    x No No Yes
R    L
x    x
width:  a   a
extent: 1   1 No Yes
R    L
x    x No None None
3/3; q/q 2 3/3 q/q R    L
x    x
x    x
x    x No No No No No No pi. Quality defects: poor definition of pleura and cut basal angles
1/1; r/r 2 1/1 r/r R    L
x    x
x    x
–    – No No No No Yes
R    L
–    x No None Quality defect: subject movement. Profusion of small opacities is more marked in right lung
2/2; r/r 2 2/2 r/r R    L
x    x
x    x
x    x No No No No No No None Quality defects: radiograph too light and contrast too high. The heart shadow is slightly displaced to the left
3/3; r/r 1 3/3 r/r R    L
x    x
x    x
x    x No No No No No No ax; ih. None
1/1; s/t 2 1/1 s/t R    L
x    –
x    x
x    x No No No No No No kl. Quality defect: cut bases. Kerley lines in lower right zone
2/2; s/s 2 2/2 s/s R    L
–   –
x    x
x    x No No No No No No em. Quality defect: distortion of bases due to shrinking. Emphysema in upper zones
3/3; s/s 2 3/3 s/s R    L
x    x
x    x
x    x No No Yes
R    L
x    x
width:  a    a
extent: 3    3 No No No ho; ih;
pi. Quality defect: radiograph is too light. Honeycomb lung appearance is not marked
1/1; t/t
Costophrenic 
angle
obliteration 1 1/1 t/t R    L
–    –
x    x
x    x No No Yes
R    L
x    x
width:  a    a
extent: 2    2 No Yes
R    L
x    – Yes
R    L
–    x
extent: 2 None This radiograph defines the lower limit for costophrenic angle obliteration. Note shrinkage in lower lung fields
2/2; t/t 1 2/2 t/t R    L
x    x
x    x
x    x No No Yes
R    L
x    x
width:  a   a
extent: 1   1 No No No ih. Pleural thickening is present in the apices of the lung
3/3; t/t 1 3/3 t/t R    L
x    x
x    x
x    x No No No No No No hi; ho;
id; ih;
tb. None
1/1; u/u
2/2; u/u
3/3; u/u This composite radiograph illustrates the mid-categories of profusion of small opacities classifiable for shape and size as u/u.
A 2 2/2 p/q R    L
x    x
x    x
x    x A No No No No No No Quality defects: radiograph is too light and pleural definition is poor
B 1 1/2 p/q R    L
x    x
x    x
x    x B No No No No No ax; co. Definition of pleura is slightly imperfect
C 1 2/1 q/t R    L
x    x
x    x
x    x C No No No No No bu; di;
em; es; hi; ih. The small opacities are difficult to classify because of the presence of the large opacities. Note the left costophrenic angle obliteration. This is not classifiable because it does not reach the lower limit defined by the standard radiograph 1/1; t/t
Pleural
thickening
(circumscribed) Yes No No No No   The pleural thickening present face on, is of indeterminate width, and extent 2
Pleural
thickening
(diffuse) No Yes No No Yes   The pleural thickening present in profile, is of width a, and extent 2. Not associated small calcifications
Pleural
thickening (calcification) diaphragm No No Yes No Yes   Circumscribed, calcified pleural thickening of extent 2
Pleural
thickening (calcification) chest wall Yes No No No Yes   Calcified and uncalcified pleural thickening present face on, is of indeterminate width, and extent 2

 

ILO 1980 Classification

The 1980 revision was carried out by the ILO with the cooperation of the Commission of the European Communities, NIOSH and the American College of Radiology. The summary of the classification is given in table 2. It retained the principle of former classifications (1968 and 1971).

Table 2. ILO 1980 International Classification of Radiographs of Pneumoconioses: Summary of details of classification

Features Codes Definitions
Technical quality
  1 Good.
  2 Acceptable, with no technical defect likely to impair classification of the radiograph of pneumoconiosis.
  3 Poor, with some technical defect but still acceptable for classification purposes.
  4 Unacceptable.
Parenchymal abnormalities
Small opacities Profusion   The category of profusion is based on assessment of the concentration of opacities by comparison with the standard radiographs.
    0/-       0/0       0/1
1/0       1/1       1/2
2/1       2/2       2/3
3/2       3/3       3/+ Category O—small opacities absent or less profuse than the lower limit of category 1.
Categories 1, 2 and 3—increasing profusion of small opacities as defined by the corresponding standard radiographs.
  Extent RU       RM       RL
LU        LM       LL The zones in which the opacities are seen are recorded. The right (R) and left (L) thorax are both divided into three zones—upper (U), middle (M) and lower (L).
The category of profusion is determined by considering the profusion as a whole over the affected zones of the lung and by comparing this with the standard radiographs.
  Shape and Size    
  Rounded p/p       q/q       r/r The letters p, q and r denote the presence of small, rounded opacities. Three sizes are defined by the appearances on standard radiographs:
p = diameter up to about 1.5 mm
q = diameter exceeding about 1.5 mm and up to about 3 mm
r = diameter exceeding about 3 mm and up to about 10 mm
  Irregular s/s        t/t         u/u The letters s, t and u denote the presence of small, irregular opacities. Three sizes are defined by the appearances on standard radiographs:
s = width up to about 1.5 mm
t = width exceeding about 1.5 mm and up to about 3 mm
u = width exceeding 3 mm and up to about 10 mm
  Mixed p/s       p/t        p/u       p/q       p/r
q/s       q/t        q/u       q/p       q/r
r/s        r/t         r/u        r/p        r/q
s/p       s/q       s/r        s/t        s/u
t/p        t/q        t/r         t/s        t/u
u/p       u/q       u/r        u/s       u/t For mixed shapes (or sizes) of small opacities, the predominant shape and size is recorded first. The presence of a significant number of another shape and size is recorded after the oblique stroke.
Large opacities   A          B          C The categories are defined in terms of the dimensions of the opacities.
Category A – an opacity having a greatest diameter exceeding about 10 mm and up to and including 50 mm, or several opacities each greater than about 10 mm, the sum of whose greatest diameters does not exceed about 50 mm.
Category B – one or more opacities larger or more numerous than those in category A whose combined area does not exceed the equivalent of the right upper zone.
Category C – one or more opacities whose combined area exceeds the equivalent of the right upper zone.
Pleural abnormalities
Pleural thickening
Chest wall Type   Two types of pleural thickening of the chest wall are recognized: circumscribed (plaques) and diffuse. Both types may occur together
  Site R                      L Pleural thickening of the chest wall is recorded separately for the right (R) and left (L) thorax.
  Width a          b          c For pleural thickening seen along the lateral chest wall the measurement of maximum width is made from the inner line of the chest wall to the inner margin of the shadow seen most sharply at the parenchymal-pleural boundary. The maximum width usually occurs at the inner margin of the rib shadow at its outermost point.
a = maximum width up to abut 5 mm
b = maximum width over about 5 mm and up to about 10 mm
c = maximum width over about 10 mm
  Face on Y          N The presence of pleural thickening seen face-on is recorded even if it can be seen also in profile. If pleural thickening is seen face-on only, width cannot usually be measured.
  Extent 1          2          3 Extent of pleural thickening is defined in terms of the maximum length of pleural involvement, or as the sum of maximum lengths, whether seen in profile or face-on.
1 = total length equivalent up to one quarter of the projection of the lateral chest wall
2 = total length exceeding one quarter but not one half of the projection of the lateral chest wall
3 = total length exceeding one half of the projection of the lateral chest wall
Diaphragm Presence Y          N A plaque involving the diaphragmatic pleura is recorded as present (Y) or absent (N), separately for the right (R) and left (L) thorax.
  Site R          L  
Costrophrenic
angle 
obliteration Presence Y          N The presence (Y) or absence (N) of costophrenic angle obliteration is recorded separately from thickening over other areas, for the right (R) and left (L) thorax. The lower limit for this obliteration is defined by a standard radiograph
  Site R          L If the thickening extends up the chest wall, then both costophrenic angle obliteration and pleural thickening should be recorded.
Pleural
calcification Site   The site and extent of pleural calcification are recorded separately for the two lungs, and the extent defined in terms of dimensions.
  Chest wall R          L  
  Diaphragm R          L  
  Other R          L “Other” includes calcification of the mediastinal and pericardial pleura.
  Extent 1          2          3 1 = an area of calcified pleura with greatest diameter up to about 20 mm, or a number of such areas the  sum of whose greatest diameters does not exceed about 20 mm.
2 = an area of calcified pleura with greatest diameter exceeding about 20 mm and up to about 100 mm, or a number of such areas the sum of whose greatest diameters exceeds about 20 mm but does not exceed about 100 mm.
3 = an area of calcified pleura with greatest diameter exceeding about 100 mm, or a number of such areas whose sum of greatest diameters exceeds about 100 mm.
Symbols
    It is to be taken that the definition of each of the symbols is preceded by an appropriate word or phrase such as “suspect”, “changes suggestive of”, or “opacities suggestive of”, etc.
  ax Coalescence of small pneumoconiotic opacities
  bu Bulla(e)
  ca Cancer of lung or pleura
  cn Calcification in small pneumoconiotic opacities
  co Abnormality of cardiac size or shape
  cp Cor pulmonale
  cv Cavity
  di Marked distortion of the intrathoracic organs
  ef Effusion
  em Definite emphysema
  es Eggshell calcification of hilar or mediastinal lymph nodes
  fr Fractured rib(s)
  hi Enlargement of hilar or mediastinal lymph nodes
  ho Honeycomb lung
  id Ill-defined diaphragm
  ih Ill-defined heart outline
  kl Septal (Kerley) lines
  od Other significant abnormality
  pi Pleural thickening in the interlobar fissure of mediastinum
  px Pneumothorax
  rp Rheumatoid pneumoconiosis
  tb Tuberculosis
Comments
  Presence Y  N Comments should be recorded pertaining to the classification of the radiograph, particularly if some other cause is thought to be responsible for a shadow which could be thought by others to have been due to pneumoconiosis; also to identify radiographs for which the technical quality may have affected the reading materially.

 

The Classification is based on a set of standard radiographs, a written text and a set of notes (OHS No. 22). There are no features to be seen in a chest radiograph which are pathognomonic of dust exposure. The essential principle is that all appearances which are consistent with those defined and represented in the standard radiographs and the guideline for the use of the ILO International Classification, are to be classified. If the reader believes that any appearance is probably or definitively not dust related, the radiograph should not be classified but an appropriate comment must be added. The 22 standard radiographs have been selected after international trials, in such a way as to illustrate the mid-categories standards of profusion of small opacities and to give examples of category A, B and C standards for large opacities. Pleural abnormalities (diffuse pleural thickening, plaques and obliteration of costophrenic angle) are also illustrated on different radiographs.

Discussion in particular at the Seventh International Pneumoconioses Conference, held in Pittsburgh in 1988, indicated the need for improvement of some parts of the classification, in particular those concerning pleural changes. A discussion group meeting on the revision of the ILO International Classification of Radiographs of Pneumoconioses was convened in Geneva by the ILO in November 1989. The experts made the suggestion that the short classification is of no advantage and can be deleted. As regards pleural abnormalities, the group agreed that this classification would now be divided into three parts: “Diffuse pleural thickening”; “Pleural plaques”; and “Costophrenic angle obliteration”. Diffuse pleural thickening might be divided into chest wall and diaphragm. They were identified according to the six zones—upper, middle and lower, of both right and left lungs. If a pleural thickening is circumscribed, it could be identified as a plaque. All plaques should be measured in centimetres. The obliteration of the costophrenic angle should be systematically noted (whether it exists or not). It is important to identify whether the costophrenic angle is visible or not. This is because of its special importance in relation to pleural diffuse thickening. Whether plaques are classified or not should be merely indicated by a symbol. The flattening of the diaphragm should be recorded by an additional symbol since it is a very important feature in asbestos exposure. The presence of plaques should be recorded in these boxes using the appropriate symbol “c” (calcified) or “h” (hyaline).

A full description of the classification, including its applications and limitation is found in the publication (ILO 1980). The revision of the classification of radiographs is a continuous ILO process, and a revised guideline should be published in the near future (1997-98) taking into account the recommendations of these experts.

 

Back

In 1919, the year of its creation, the International Labour Organization (ILO) declared that anthrax was an occupational disease. In 1925, the first ILO List of Occupational Diseases was established by the Workmen’s Compensation (Occupational Diseases) Convention (No. 18). There were three occupational diseases listed. Convention No. 42 (1934) revised Convention No. 18 with a list of ten occupational diseases. In 1964, the International Labour Conference adopted the Employment Injury Benefits Convention (No. 121), this time with a separate schedule (List of Occupational Diseases) appended to the Convention, which allows for amending the schedule without having to adopt a new Convention (ILO 1964).

Definition of Work-Related Diseases and Occupational Diseases

In the third edition of the ILO’s Encyclopaedia of Occupational Health and Safety, a distinction was made among the pathological conditions that could affect workers in which diseases due to occupation (occupational diseases) and diseases aggravated by work or having a higher incidence owing to conditions of work (work-related diseases) were separated from conditions having no connection with work. However, in some countries work-related diseases are treated the same as work-caused diseases, which are in fact occupational diseases. The concepts of work-related diseases and occupational diseases have always been a matter of discussion.

In 1987, a joint ILO/WHO expert committee on occupational health offered the suggestion that the term work-related diseases may be appropriate to describe not only recognized occupational diseases, but other disorders to which the work environment and performance of work contribute significantly as one of the several causative factors (Joint ILO/WHO Committee on Occupational Health 1989). When it is clear that a causal relationship exists between an occupational exposure and a specific disease, that disease is usually considered both medically and legally as occupational and may be defined as such. However, not all work-related diseases can be defined so specifically. The ILO Employment Injury Benefits Recommendation, 1964 (No. 121), paragraph 6(1), defines occupational disease as follows: “Each Member should, under prescribed conditions, regard diseases known to arise out of the exposure to substances and dangerous conditions in processes, trades or occupations as occupational diseases.”

Nevertheless, it is not always that easy to designate a disease as being work-related. In fact, there is a wide range of diseases that could be related in one way or another to occupation or working conditions. On the one hand, there are the classical diseases that are occupational in nature, generally related to one causal agent and relatively easy to identify. On the other hand, there are all sorts of disorders without strong or specific connections to occupation and with numerous possible causal agents.

Many of these diseases with a multifactorial aetiology may be work-related only under certain conditions. The subject was discussed at an international symposium on work-related diseases organized by the ILO in Linz, Austria, in October 1992 (ILO 1993). The relationship between work and disease could be identified in the following categories:

    • occupational diseases, having a specific or a strong relation to occupation, generally with only one causal agent, and recognized as such
    • work-related diseases, with multiple causal agents, where factors in the work environment may play a role, together with other risk factors, in the development of such diseases, which have a complex aetiology
    • diseases affecting working populations, without causal relationship with work but which may be aggravated by occupational hazards to health.

         

        Criteria for Identification of Occupational Diseases in General

        Two main elements are present in the definition of occupational diseases:

          • the exposure-effect relationship between a specific working environment and/or activity and a specific disease effect
          • the fact that these diseases occur among the group of persons concerned with a frequency above the average morbidity of the rest of the population.

             

            It is apparent that the exposure-effect relationship must be clearly established: (a) clinical and pathological data and (b) occupational background and job analysis are indispensable, while (c) epidemiological data are useful, for determining the exposure-effect relationship of a specific occupational disease and its corresponding activity in specific occupations.

            As a general rule, the symptoms of such disorders are not sufficiently characteristic to enable occupational diseases to be diagnosed other than on the basis of the knowledge of the pathological changes engendered by the physical, chemical, biological or other factors encountered in the exercise of an occupation. It is therefore normal that, as a result of the improvement of knowledge regarding the action processes of the factors in question, the steady increase in the number of substances employed, and the quality used or the variety of agents suspected, it should be more and more possible to make an accurate diagnosis while at the same time broadening the range of these diseases. Parallel with the boom in the research in this field, the development and refinement of epidemiological surveys have made a substantial contribution towards furthering the knowledge of exposure/effect relationships, making it easier, inter alia, to define and identify the various occupational diseases. The identification of a disease as being of occupational origin is, in reality, a specific example of clinical decision-making or applied clinical epidemiology. Deciding on the cause of a disease is not an exact science but rather a question of judgement based on a critical review of all the available evidence, which should include a consideration of:

              • Strength of association. An occupational disease is one where there is an obvious and real increase in disease in association with exposure to the risk.
              • Consistency. The various research reports have generally similar results and conclusions.
              • Specificity. The risk exposure results in a clearly defined pattern of disease or of diseases and not simply in an increasing number of causes of morbidity or mortality.
              • Appropriate time relationship. The disease follows after the exposure and with an appropriate time interval.
              • Biological gradient. The greater the level of exposure, the greater the prevalence of severity of diseases.
              • Biological plausibility. From what is known of toxicology, chemistry, physical properties or other attributes of the studied risk, it does really make biological sense to suggest that the exposure leads to a certain disorder.
              • Coherence. A general synthesis of all the evidence (human epidemiology, animal studies and so on) leads to the conclusion that there is a causative effect in its broad sense and in terms of general common sense.

                           

                          The magnitude of the risk is another basic element generally used for determining whether a disease is to be considered occupational in origin. Quantitative and qualitative criteria play an important role in evaluating the risk of contracting an occupational disease. Such a risk may be expressed either in terms of its magnitude—for instance, the quantities in which the substance is employed, the number of workers exposed, the prevalence rates for the disease in different countries—or in terms of the seriousness of the risk, which may be assessed on the basis of its effects upon workers’ health (e.g., the likelihood of its causing cancer or mutations or having highly toxic effects or leading in due course to disablement). It should be noted that the figures available as to prevalence rates and the degree of seriousness of occupational diseases should be viewed with some circumspection due to the differences in procedures for reporting cases and compiling and evaluating data. The same is true for the number of workers exposed, as figures can only be approximate.

                          Finally, at the international level, another very important factor must be taken into account: the fact that the disease is recognized as being occupational by the law of a certain number of countries constitutes an important criterion on which to base a decision to include it in the international list. It may indeed be considered that its incorporation in the list of diseases carrying entitlement to benefit in a large number of countries shows that it is of considerable social and economic importance and that the risk factors involved are recognized and widely encountered.

                          To summarize, criteria for determining a new occupational disease to be added on an international list are: the strength of the exposure-effect relationship, the occurrence of the disease with specific activity or specific work environment (which includes the occurrence of the event and a specific nature of this relationship), the magnitude of the risk on the basis of the number of workers exposed or the seriousness of the risk, and the fact that a disease is recognized on many national lists.

                          Criteria for Identification of an Individual Disease

                          The exposure-effect relationship (relation between exposure and the severity of the impairment in the subject) and the exposure-response relationship (connection between exposure and the relative number of subjects affected) are important elements for the determination of occupational diseases, which research and epidemiological studies have greatly contributed to developing in the last decade. This information pertaining to the causal relationship between diseases and exposure in the workplace has allowed us to achieve a better medical definition of occupational diseases. Therefore it follows that the legal definition of occupational diseases, which was a rather complex problem before, is becoming more and more linked to the medical definitions. The legal system entitling the victim to compensation varies from country to country. Article 8 of the Employment Injury Benefits Convention (No. 121), which indicates the various possibilities regarding the form of the schedule of occupational diseases entitling workers to a compensation benefit, states:

                          Each Member shall:

                          1. prescribe a list of diseases, comprising at least the diseases enumerated in Schedule I to this Convention, which shall be regarded as occupational diseases under prescribed conditions; or
                          2. include in its legislation a general definition of occupational diseases broad enough to cover at least the diseases enumerated in Schedule I to this Convention; or
                          3. prescribe a list of diseases in conformity with clause (a), complemented by a general definition of occupational diseases or by other provisions for establishing the occupational origin of diseases not so listed or manifesting themselves under conditions different from those prescribed.

                          Point (a) is called the list system, point (b) is the general definition system or overall coverage system while point (c) is generally referred to as the mixed system.

                          While the list system has the disadvantage of covering only a certain number of occupational diseases, it has the advantage of listing diseases for which there is a presumption that they are of occupational origin. Frequently it is very difficult if not impossible to prove that a disease is directly attributable to the victim’s occupation. Paragraph 6(2) of Recommendation No. 121 indicates that “Unless proof to the contrary is brought, there should be a presumption of the occupational origin of such diseases” (under prescribed conditions). It also has the important advantage of indicating clearly where prevention should take place.

                          The general definition system covers theoretically all occupational diseases; it affords the widest and most flexible protection, but leaves it to the victim to prove the occupational origin of the disease, and no emphasis is placed on specific prevention.

                          Because of this marked difference between a general definition and a list of specific diseases, the mixed system has been favoured by many ILO Member States because it combines the advantages of the two others without their disadvantages.

                          List of Occupational Diseases

                          Convention No. 121 and Recommendation No. 121

                          The ILO list plays a key role in harmonizing the development of policy on occupational diseases and in promoting their prevention. It has in fact achieved considerable status in the field of occupational health and safety. It presents a clear statement of diseases or disorders that can and should be prevented. As it is, it does not include all occupational diseases. It should represent those that are most common in the industries of many countries and where prevention can have the greatest impact on the health of workers.

                          Because the patterns of employment and risks are changing greatly and continuously in many countries, and because of the evolution of knowledge on occupational diseases through epidemiological studies and research, the list must be modified and added to, reflecting an updated state of knowledge, to be fair to the victims of these diseases.

                          In developed countries, heavy industries such as steel fabrication and underground mining have greatly diminished, and environmental conditions have improved. Service industries and automated offices have risen in relative importance. A far greater proportion of the workforce is made up of women who still, for the most part, manage the home and care for children in addition to working on the outside. The need for day care for children is increasing while these developments place added stress on women. Night work and rotating shift work have become a normal pattern. Stress, in all aspects, is now an important problem.

                          In developing countries, heavy industries are rising rapidly to supply local and export needs, and providing employment to these burgeoning populations. Rural populations are moving to cities in search of employment and to escape poverty.

                          The human health risks of some new chemicals are known, and special emphasis is given to short-term biological tests or to long-term animal exposures for the purpose of toxicological and carcinogenic incidence. Exposures of working populations in most developed countries are probably controlled at low levels, but no such assurance can be assumed for the use of chemicals in many other nations. A particularly important example is provided by the use of pesticides and herbicides in agriculture. Although there can be no serious doubt that they increase crop yields in the short term as well as increasing the control of vector-borne diseases such as malaria, we do not know clearly in which controlled conditions they can be used without major impact on the health of agricultural workers or those who eat the foods so produced. It seems that in certain countries, very large numbers of agricultural workers have been poisoned by their use. Even in well industrialized countries the health of farm workers is a serious problem. The isolation and lack of supervision place them at real risk. A prominent issue is provided by the continued manufacture of some chemicals in countries where their use is banned, in order to export these chemicals to countries where no such ban exists.

                          The design and function of enclosed modern buildings in industrialized countries and of the electronic office equipment within them have received close attention. Continuous repetitive movements are widely considered to be the cause of debilitating symptoms.

                          Tobacco smoke in the workplace, although not seen as a cause of occupational disease by itself, seems likely to be an issue in the future. Non-smokers are increasingly intolerant of the perceived health hazard from the smoke emitted by smokers in the vicinity. The pressure to sell tobacco products in developing countries is likely to produce an unprecedented epidemic of diseases in the near future. Exposure of non-smokers to tobacco smoke pollution will have to be taken as a matter of increasing consideration. Relevant legislation is already in place in some countries. A most important hazard is associated with health care workers who are exposed to a wide variety of chemicals, sensitizers and infections. Hepatitis and AIDS provide special examples.

                          The entry of women into the workforce in all countries underlies the problem of reproductive disorders associated with workplace factors. These include infertility, sexual dysfunction and effects on foetus and pregnancy when the women are exposed to chemical agents and workplace factors, including ergonomic strain. There is increasing evidence that the same problems may affect male workers.

                          Within this framework of changing populations and changing patterns of risk, it is necessary to review the list and add those diseases identified as being occupational. The list appended to Convention No. 121 should accordingly be brought up to date so as to include the disorders most widely recognized as being of occupational origin and those involved in most dangers to health. In this regard, an informal consultation on the revision of the list of occupational diseases appended to Convention No. 121 was held by the ILO in Geneva in December 1991. In their report, the experts proposed a new list, which is shown in table 1.

                           


                          Table 1. Proposed ILO list of occupational diseases

                           

                          1.

                          Diseases caused by agents

                           

                          1.1

                          Diseases caused by chemical agents

                           

                           

                          1.1.1

                          Diseases caused by beryllium or its toxic compounds

                           

                           

                          1.1.2

                          Diseases caused by cadmium or its toxic compounds

                           

                           

                          1.1.3

                          Diseases caused by phosphorus or its toxic compounds

                           

                           

                          1.1.4

                          Diseases caused by chromium or its toxic compounds

                           

                           

                          1.1.5

                          Diseases caused by manganese or its toxic compounds

                           

                           

                          1.1.6

                          Diseases caused by arsenic or its toxic compounds

                           

                           

                          1.1.7

                          Diseases caused by mercury or its toxic compounds

                           

                           

                          1.1.8

                          Diseases caused by lead or its toxic compounds

                           

                           

                          1.1.9

                          Diseases caused by fluorine or its toxic compounds

                           

                           

                          1.1.10

                          Diseases caused by carbon disulphide

                           

                           

                          1.1.11

                          Diseases caused by the toxic halogen derivatives of aliphatic or aromatic hydrocarbons

                           

                           

                          1.1.12

                          Diseases caused by benzene or its toxic homologues

                           

                           

                          1.1.13

                          Diseases caused by toxic nitro- and amino-derivatives of benzene or its homologues

                           

                           

                          1.1.14

                          Diseases caused by nitroglycerin or other nitric acid esters

                           

                           

                          1.1.15

                          Diseases caused by alcohols glycols or ketones

                           

                           

                          1.1.16

                          Diseases caused by asphyxiants: carbon monoxide hydrogen cyanide or its toxic derivatives hydrogen sulphide

                           

                           

                          1.1.17

                          Diseases caused by acrylonitrite

                           

                           

                          1.1.18

                          Diseases caused by oxides of nitrogen

                           

                           

                          1.1.19

                          Diseases caused by vanadium or its toxic compounds

                           

                           

                          1.1.20

                          Diseases caused by antimony or its toxic compounds

                           

                           

                          1.1.21

                          Diseases caused by hexane

                           

                           

                          1.1.22

                          Diseases of teeth due to mineral acids

                           

                           

                          1.1.23

                          Diseases due to pharmaceutical agents

                           

                           

                          1.1.24

                          Diseases due to thallium or its compounds

                           

                           

                          1.1.25

                          Diseases due to osmium or its compounds

                           

                           

                          1.1.26

                          Diseases due to selenium or its toxic compounds

                           

                           

                          1.1.27

                          Diseases due to copper or its compounds

                           

                           

                          1.1.28

                          Diseases due to tin or its compounds

                           

                           

                          1.1.29

                          Diseases due to zinc or its toxic compounds

                           

                           

                          1.1.30

                          Diseases due to ozone, phosgene

                           

                           

                          1.1.31

                          Diseases due to irritants: benzoquinone and other corneal irritants

                           

                           

                          1.1.32

                          Diseases caused by any other chemical agents not mentioned in the preceding items 1.1.1 to 1.1.31 where a link between the exposure of a worker to this chemical agent and the disease suffered is established.

                           

                          1.2

                          Diseases caused by physical agents

                           

                           

                          1.2.1

                          Hearing impairment caused by noise

                           

                           

                          1.2.2

                          Diseases caused by vibration (disorders of muscles, tendons, bones, joints, peripheral blood vessels or peripheral nerves)

                           

                           

                          1.2.3

                          Diseases caused by work in compressed air

                           

                           

                          1.2.4

                          Diseases caused by ionizing radiation

                           

                           

                          1.2.5

                          Diseases caused by heat radiation

                           

                           

                          1.2.6

                          Diseases caused by ultra violet radiation

                           

                           

                          1.2.7

                          Diseases due to extreme temperature (e.g., sunstroke, frostbite)

                           

                           

                          1.2.8

                          Diseases caused by any other physical agents not mentioned in the preceding items 1.2.1 to 1.2.7 where a direct link between the exposure of a worker to this physical agent and the disease suffered is established.

                           

                          1.3

                          Biological agents

                           

                           

                          1.3.1

                          Infections or parasitic diseases contracted in an occupation where there is a particular risk of contamination

                          2.

                          Diseases by target organ systems

                           

                          2.1

                          Occupational respiratory diseases

                           

                           

                          2.1.1

                          Pneumoconioses caused by sclerogenic mineral dust (silicosis, anthraco-silicosis, asbestosis) and silicotubercolosis, provided that silicosis is an essential factor in causing the resultant incapacity or death

                           

                           

                          2.1.2

                          Bronchopulmonary diseases caused by hard-metal dust

                           

                           

                          2.1.3

                          Bronchopulmonary diseases caused by cotton, flax, hemp or sisal dust (byssinosis)

                           

                           

                          2.1.4

                          Occupational asthma caused by recognized sensitizing agents or irritants inherent to the work process

                           

                           

                          2.1.5

                          Extrinsic allergic alveolitis caused by the inhalation of organic dusts as prescribed by national legislation

                           

                           

                          2.1.6

                          Siderosis

                           

                           

                          2.1.7

                          Chronic obstructive pulmonary diseases

                           

                           

                          2.1.8

                          Diseases of lung due to aluminium

                           

                           

                          2.1.9

                          Upper airways disorders caused by recognized sensitizing agents or irritants inherent to the work process

                           

                           

                          2.1.10

                          Any other respiratory disease not mentioned in the preceding items 2.1.1 to 2.1.9 caused by an agent where a direct link between the exposure of a worker to this agent and the disease suffered is established

                           

                          2.2

                          Occupational skin diseases

                           

                           

                          2.2.1

                          Skin diseases caused by physical, chemical, or biological agents not included under other items

                           

                           

                          2.2.2

                          Occupational vitiligo

                           

                          2.3

                          Occupational musculo-skeletal disorders

                           

                           

                          2.3.1

                          Musculo-skeletal diseases caused by specific work activities or work environment where particular risk factors are present.

                          Examples of such activities or environment include:

                          (a) Rapid or repetitive motion

                          (b) Forceful exertions

                          (c) Excessive mechanical force concentrations

                          (d) Awkward or non-neutral postures

                          (e) Vibration

                          Local or environmental cold may potentiate risk.

                           

                           

                          2.3.2

                          Miner’s nystagmus

                          3.

                          Occupational cancer

                           

                          3.1

                          Cancer caused by the following agents:

                           

                           

                          3.1.1

                          Asbestos

                           

                           

                          3.1.2

                          Benzidine and salts

                           

                           

                          3.1.3

                          Bichloromethyl ether (BCME)

                           

                           

                          3.1.4

                          Chromium and chromium compounds

                           

                           

                          3.1.5

                          Coal tars and coal tar pitches; soot

                           

                           

                          3.1.6

                          Beta-naphthylamine

                           

                           

                          3.1.7

                          Vinyl chloride

                           

                           

                          3.1.8

                          Benzene or its toxic homologues

                           

                           

                          3.1.9

                          Toxic nitro- and amino-derivatives of benzene or its homologues

                           

                           

                          3.1.10

                          Ionizing radiation

                           

                           

                          3.1.11

                          Tar, pitch, bitumen, mineral oil, anthracene, or the compounds, products or residues of these substances

                           

                           

                          3.1.12

                          Coke oven emissions

                           

                           

                          3.1.13

                          Compounds of nickel

                           

                           

                          3.1.14

                          Dust from wood

                           

                           

                          3.1.15

                          Cancer caused by any other agents not men- tioned in the preceding items 3.1.1 to 3.1.14 where a direct link between the exposure of a worker to this agent and the cancer suffered is established.

                           


                           

                          In their report, the experts indicated that the list should be brought up to date regularly to contribute to harmonizing social security benefits at the international level. It was clearly indicated that there is no moral or ethical reason to recommend standards in one country that are lower than those in another. Additional reasons to revise this list frequently include (1) stimulating the prevention of occupational diseases by facilitating a greater awareness of the risks involved in work, (2) encouraging combating the use of harmful substances, and (3) keeping workers under medical surveillance. The prevention of occupational diseases remains an essential objective of any system of social security concerned with the protection of workers’ health.

                          A new format has been proposed, breaking down the list into the three following categories:

                          1. diseases caused by agents (chemical, physical, biological)
                          2. diseases of target organ systems (respiratory, skin, musculoskeletal)
                          3. occupational cancer.

                           

                          Back

                          " DISCLAIMER: The ILO does not take responsibility for content presented on this web portal that is presented in any language other than English, which is the language used for the initial production and peer-review of original content. Certain statistics have not been updated since the production of the 4th edition of the Encyclopaedia (1998)."

                          Contents